Valuation (12%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -5.59 | 45.57 |
PEG Ratio (TTM) | -0.06 | 1.01 |
P/S Ratio (TTM) | 7.49 | 17.12 |
P/B Ratio (TTM) | 5.50 | 16.75 |
P/FCF Ratio (TTM) | -0.93 | 40.14 |
Price to 5YR AVG Earnings Ratio | N/A | 63.04 |
Price to 5YR AVG FCF Ratio | N/A | 98.76 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -88.18% | -2.56% |
ROE (TTM) | -68.62% | 10.12% |
Net Profit Margin (TTM) | -1,874.60% | 4.50% |
ROIC 5YR AVG | N/A | 3.39% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 14.14% | N/A | N/A |
Revenue | -3.75% | N/A | N/A |
Net Income | 12.21% | N/A | N/A |
Cash Flow | -2.32% | N/A | N/A |
Health (47%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 11.08 | 1.92 |
Quick Ratio (TTM) | 11.08 | 1.91 |
D/E Ratio (TTM) | 0.01 | 0.57 |
Interest Coverage (TTM) | -0.57 | 11.84 |
Piotroski F-Score | 3 | 6 |
Altman Z-Score | 0.29 | 10.66 |
LTL to 5YR AVG FCF | N/A | 3.74 |
Shares Outstanding Growth 5YR AVG | N/A | 44.60% |